NCT06045481View on ClinicalTrials.gov

Postexposure Prophylaxis With Single Dose Doxycycline for the Prevention of Tick-borne Relapsing Fever

NANot yet recruitingINTERVENTIONAL

Enrollment

526

Participants

Timeline

Start Date

August 1, 2024

Primary Completion Date

October 31, 2026

Study Completion Date

October 31, 2027

Conditions

Relapsing Fever, Tick-Borne

Interventions

DRUG

administration of single dose of doxycycline

Postexposure prophylaxis with Single Dose doxycycline

All Listed Sponsors

lead

Medical Corps, Israel Defense Force

OTHER

NCT06045481 - Postexposure Prophylaxis With Single Dose Doxycycline for the Prevention of Tick-borne Relapsing Fever | Biotech Hunter | Biotech Hunter